TABLE 3.
Isolate | MIC (mg/liter) ofb
: |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ATM | ATM-AVI | ATM-CLAV | ATM-REL | ATM-VAB | AMOX-CLAV | CAZ-AVI | IMI-REL | LFX | MER-VAB | TMP-SMZc | |
SM-1d | ≥256 | 0.5 | 2 | 4 | 8 | ≥256 | 32 | ≥64 | >16 | 32 | 8 |
SM-2 | ≥256 | 4 | 8 | 16 | 128 | ≥256 | 64 | ≥64 | 2 | ≥64 | ≥16 |
SM-3 | ≥256 | 1 | 4 | 4 | 64 | ≥256 | 128 | ≥64 | 16 | ≥64 | 8 |
SM-4 | ≥256 | 8 | ≥256 | 16 | ≥256 | ≥256 | 64 | ≥64 | 1 | 32 | ≥16 |
SM-5d | ≥256 | 2 | ≥256 | 4 | 64 | ≥256 | ≥256 | ≥64 | 8 | 32 | 8 |
SM-6d | ≥256 | 16 | 128 | 128 | ≥256 | ≥256 | ≥256 | ≥64 | 4 | ≥64 | 0.5 |
AVI was tested at 4 mg/liter, CLAV was tested at 2 mg/liter, REL was tested at 4 mg/liter, and VAB was tested at 8 mg/liter.
ATM, aztreonam; AVI, avibactam; CLAV, clavulanate; REL, relebactam; VAB, vaborbactam; AMOX, amoxicillin; CAZ, ceftazidime; IMI, imipenem; LFX, levofloxacin; MER, meropenem; TMP-SMZ, trimethoprim-sulfamethoxazole.
Reflects the MIC of the trimethoprim component.
Subjected to whole-genome sequencing and quantitative reverse transcriptase PCR analysis.